The direct, indirect and intangible costs of visual impairment caused by neovascular age-related macular degeneration

Author： Ke Kathleen  

Publisher： Springer Publishing Company

ISSN： 1618-7598

Source： The European Journal of Health Economics, Vol.11, Iss.6, 2010-12, pp. : 525-531

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Visual outcomes in patients with neovascular age‐related macular degeneration

By  

ACTA OPHTHALMOLOGICA, Vol. 96, Iss. 2, 2018-03 ,pp. : e254-e254

John Wiley & Sons Inc

Access to resources Recommend Favorite

Gold nanoparticle enhancement of stereotactic radiosurgery for neovascular age-related macular degeneration

By Ngwa Wilfred   Makrigiorgos G Mike   Berbeco Ross I  

Physics in Medicine and Biology, Vol. 57, Iss. 20, 2012-10 ,pp. : 6371-6380

IOP Publishing

Access to resources Recommend Favorite

Burden of illness of bilateral neovascular age-related macular degeneration in Spain*

By María Ruiz-Moreno José   María Coco Rosa   García-Arumí José   Xu Xiao   Zlateva Gergana  

Current Medical Research and Opinion, Vol. 24, Iss. 7, 2008-07 ,pp. : 2103-2111

Informa Healthcare

Access to resources Recommend Favorite

An epidemiological study of neovascular age-related macular degeneration in Germany

By Krause Lothar   Yousif Tarik   Pohl Karin    

Current Medical Research and Opinion, Vol. 29, Iss. 10, 2013-10 ,pp. : 1391-1397

Informa Healthcare

Access to resources Recommend Favorite

Implementation studies of ranibizumab for neovascular age‐related macular degeneration

By  

ACTA OPHTHALMOLOGICA, Vol. 92, Iss. 1, 2014-02 ,pp. : 98-98

John Wiley & Sons Inc

Access to resources Recommend Favorite